J&J Propulsid Compassionate IND Program Expands To Allow Emergency Use
Executive Summary
Janssen is adding three IND treatment protocols to its limited access program for Propulsid (cisapride).
You may also be interested in...
FDA Calls For Pre-Market CV Safety Trials For Some Constipation Drugs
Serotonin receptor 4 agonists for use in constipation have been in limbo due to potential for CV risk; FDA is seeking recommendations about safety studies for the class from an advisory committee.
FDA Warns Compounding Pharmacies On Ribavirin, Propulsid Versions
A recent spate of enforcement actions by FDA against compounding pharmacies includes citations for compounded versions of ribavirin and Propulsid
FDA Warns Compounding Pharmacies On Ribavirin, Propulsid Versions
A recent spate of enforcement actions by FDA against compounding pharmacies includes citations for compounded versions of ribavirin and Propulsid